- Home
- LANV vs QSI Comparison
LANV vs QSI Comparison
Compare LANV & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LANV | QSI |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | China | United States |
| Employees | 2066 | 145 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.9M | 165.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LANV | QSI |
|---|---|---|
| Price | $1.13 | $0.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 11.4K | ★ 2.6M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.33 | $618.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.69 |
| 52 Week High | $2.54 | $3.10 |
Technical Indicators
Market Signals| Indicator | LANV | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 39.28 |
| Support Level | $1.03 | $0.69 |
| Resistance Level | $1.79 | $1.04 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 26.47 | 29.37 |
Price Performance
Historical ComparisonAbout LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.